These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 27226093)

  • 41. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.
    Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D
    Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of influenza A infection on umbilical cord blood natural killer function regulation with interleukin-15.
    Lin SJ; Cheng PJ; Lin TY; Lee PT; Hsiao HS; Kuo ML
    J Infect Dis; 2012 Mar; 205(5):745-56. PubMed ID: 22262794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence.
    Strowig T; Chijioke O; Carrega P; Arrey F; Meixlsperger S; Rämer PC; Ferlazzo G; Münz C
    Blood; 2010 Nov; 116(20):4158-67. PubMed ID: 20671122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bladder tumor ILC1s undergo Th17-like differentiation in human bladder cancer.
    Mukherjee N; Ji N; Tan X; Lin CL; Rios E; Chen CL; Huang T; Svatek RS
    Cancer Med; 2021 Oct; 10(20):7101-7110. PubMed ID: 34496133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of an early myelopoietic antigen (CD33) on a subset of human umbilical cord blood-derived natural killer cells.
    Handgretinger R; Schäfer HJ; Baur F; Frank D; Ottenlinger C; Bühring HJ; Niethammer D
    Immunol Lett; 1993 Aug; 37(2-3):223-8. PubMed ID: 7505004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers.
    Morgan AJ; Guillen C; Symon FA; Birring SS; Campbell JJ; Wardlaw AJ
    Immunobiology; 2008; 213(7):599-608. PubMed ID: 18656707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human Bone Marrow-Resident Natural Killer Cells Have a Unique Transcriptional Profile and Resemble Resident Memory CD8
    Melsen JE; Lugthart G; Vervat C; Kielbasa SM; van der Zeeuw SAJ; Buermans HPJ; van Ostaijen-Ten Dam MM; Lankester AC; Schilham MW
    Front Immunol; 2018; 9():1829. PubMed ID: 30186282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
    Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
    Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The IL-12 signature: NK cell terminal CD56+high stage and effector functions.
    Loza MJ; Perussia B
    J Immunol; 2004 Jan; 172(1):88-96. PubMed ID: 14688313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD56
    Judge CJ; Kostadinova L; Sherman KE; Butt AA; Falck-Ytter Y; Funderburg NT; Landay AL; Lederman MM; Sieg SF; Sandberg JK; Anthony DD
    J Leukoc Biol; 2017 Jul; 102(1):171-184. PubMed ID: 28400540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decrease in the Frequency of Circulating CD56
    Rai AK; Thakur CP; Kumar P; Saini S; Kureel AK; Kumari S; Seth T; Mitra DK
    Immunol Invest; 2018 Feb; 47(2):125-134. PubMed ID: 29182405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel epitope of N-CAM defines precursors of human adherent NK cells.
    Li S; Xu J; Makarenkova VP; Tjandrawan T; Vakkila J; Reichert T; Gooding W; Lagenaur CF; Achim CL; Chambers WH; Herberman RB; Whiteside TL; Vujanovic NL
    J Leukoc Biol; 2004 Dec; 76(6):1187-99. PubMed ID: 15356097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating NK cells and their subsets in Behçet's disease.
    Hasan MS; Ryan PL; Bergmeier LA; Fortune F
    Clin Exp Immunol; 2017 May; 188(2):311-322. PubMed ID: 28170096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells.
    Márquez ME; Millet C; Stekman H; Conesa A; Deglesne PA; Toro F; Sanctis JD; Blanca I
    Cell Immunol; 2010; 264(1):86-92. PubMed ID: 20553754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T-cell factor-1 expression during human natural killer cell development and in circulating CD56(+) bright natural killer cells.
    Toor AA; Lund TC; Miller JS
    Exp Hematol; 2001 Apr; 29(4):499-506. PubMed ID: 11301190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulation of cell surface CXCR6 expression during T cell activation is predominantly mediated by calcineurin.
    Koprak S; Matheravidathu S; Springer M; Gould S; Dumont FJ
    Cell Immunol; 2003 May; 223(1):1-12. PubMed ID: 12914753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation.
    Michelo CM; Fasse E; van Cranenbroek B; Linda K; van der Meer A; Abdelrazik H; Joosten I
    Transpl Immunol; 2016 Jul; 37():1-9. PubMed ID: 27142560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection.
    Rutjens E; Mazza S; Biassoni R; Koopman G; Ugolotti E; Fogli M; Dubbes R; Costa P; Mingari MC; Greenwood EJ; Moretta L; De Maria A; Heeney JL
    Eur J Immunol; 2010 May; 40(5):1440-50. PubMed ID: 20306468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases.
    Borrego F; Peña J; Solana R
    Eur J Immunol; 1993 May; 23(5):1039-43. PubMed ID: 8477800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.
    Keating SE; Zaiatz-Bittencourt V; Loftus RM; Keane C; Brennan K; Finlay DK; Gardiner CM
    J Immunol; 2016 Mar; 196(6):2552-60. PubMed ID: 26873994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.